Schrödinger

Schrödinger

Health Care Technology
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

$1.4B

Market Cap • 9/11/2026

1995

(31 years)

Founded

2020

(6 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

4,3

P/S

5,4

P/EBITDA

P/OCF

P/FCF

P/E

BVPS

4,4

EPS

Market Cap

Market Cap

1,4B

EV

1,1B

EV/Revenue

4,2

EV/EBITDA

-6,6

EV/EBIT

-7,1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-0,1%

Total Yield

-0,1%

Payout

0%

Retained Earnings

-682,9M

Profitability

Gross Margin

56,9%

EBITDA Margin

EBIT Margin

Net Margin

D&A/EBITDA

0%

R&D/Revenue

65,2%

Capex/Revenue

1,3%

Capex/D&A

-25,7%

Capex/OCF

-2,7%

SBC/OCF

% PPE

18,8%

% Goodwill

0,7%

ROE

ROIC

Growth

CAGR Revenue 5Y

16,5%

CAGR Op. Income 5Y

12,2%

CAGR Net Income 5Y

4,4%

CAGR EPS 5Y

4,5%

CAGR OCF 5Y

70,9%

Leverage

N.D./EBITDA

1,9

Debt/Equity

0%

Current Ratio

2,7

Quick Ratio

2,4

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium